Sandoz Linezolid · DIN 02422689 · 600 mg · tablet
Limited Use, Reason for Use code 362, 363, 364 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 362, 363, 364 required
Write on scriptone applicable Reason for Use code, 362 or 363 or 364 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 362, 363, 364
Coverage limit:
For the treatment of patients with:
Reason for Use code 362
Methicillin-resistant Staphylococcus species (MRSA, MRSE) infections* in patients who are intolerant or have failed vancomycin therapy, or have contraindications to venous access.
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 363
Vancomycin resistant Enterococcus species (VRE) infections* in patients switching from IV linezolid.
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 364
Step-down therapy for the treatment of methicillin-resistant Staphylococcus species or vancomycin resistant Enterococcus species (VRE) infections* after parenteral therapy or hospital/ emergency department discharge.
Coverage limit:
* Infections must be documented and culture proven. Not approved for colonization (e.g. nares, urine, etc). Maximum 28 days supply.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Sandoz Linezolid · DIN 02422689
Manufacturer: Sandoz Canada Inc.; listing date 2014-10-29
Health Canada: Marketed since 2014-08-25 · brand SANDOZ LINEZOLID · ATC J01XX08 LINEZOLID · form Tablet · route Oral · ingredients LINEZOLID 600 MG · company Sandoz canada incorporated · schedule Prescription
Sandoz Linezolid: Formulary list price $19.30 per unit (the source does not state the unit; exact figure $19.3041). What the ministry pays, not the patient.
Ministry pays: $19.3041 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02422689)
Source record
DIN 02422689: Sandoz Linezolid
Raw flags: sec12=Y, sec3=Y
Item: 084000054; group id 136; item number 0229; lccId 00014; manufacturer id SDZ
Source form: Tab; strength: 600mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $19.3041; ministry $19.3041
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02422689
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90735
Interchangeable products
Apo-Linezolid · DIN 02426552 · $19.3041
Jamp Linezolid · DIN 02520354 · $19.3041
Zyvoxam · DIN 02243684 · not recorded
Shortage status: resolved shortage (ended November 7, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02422689
Shortage record checked October 6, 2026